What is the current DNA & RNA Extraction market size?

The DNA & RNA Extraction market size was valued at USD 1.2 billion in 2023, driven by advancements in molecular diagnostics and biotechnology applications.

What is the projected growth rate for the DNA & RNA Extraction market?

The market is forecasted to grow at a CAGR of 5.5% from 2024 to 2030, with increasing demand for genetic research and personalized medicine.

What are the key drivers of the DNA & RNA Extraction market?

Growth is fueled by rising R&D investments in genomics, adoption of automation, and expansion of biobanking and pharmacogenomics initiatives.

What challenges hinder the DNA & RNA Extraction market?

High extraction costs, technical complexities, and regulatory hurdles for novel extraction technologies pose significant challenges.

Which regions lead the DNA & RNA Extraction market?

North America dominates with 40% market share, followed by Europe and Asia-Pacific, due to strong healthcare infrastructure and R&D hubs.

Who are the top companies in the DNA & RNA Extraction market?

Leading firms include Thermo Fisher Scientific, Qiagen, and Illumina, which leverage innovation and strategic partnerships to maintain market share.

What future opportunities exist in the DNA & RNA Extraction market?

Emerging opportunities lie in point-of-care diagnostics, CRISPR-based technologies, and expanding applications in agricultural biotechnology.

How does technology impact the DNA & RNA Extraction market?

Advances in microfluidics, magnetic beads, and AI-driven automation enhance efficiency, accuracy, and scalability of extraction processes.

What is the regulatory landscape for DNA & RNA Extraction products?

Regulatory frameworks like FDA and EMA guidelines ensure standardized quality, while evolving policies on genetic data privacy shape market strategies.

DNA & RNA Extraction Growth Analysis & Future Outlook 2033

DNA & RNA Extraction by Application (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies), by Types (DNA/RNA Extraction Equipment, DNA/RNA Extraction Reagents), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $4470 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $4470 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

DNA & RNA Extraction Market Overview

The DNA & RNA Extraction market encompasses technologies and methodologies used to isolate nucleic acids for applications in genomics, diagnostics, biotechnology, and pharmaceutical research. As precision medicine and infectious disease surveillance drive demand, the market is poised for sustained growth. The global DNA & RNA Extraction market size reached USD 1.3 billion in 2025, with a projected CAGR of 6.7% from 2026 to 2033, reaching USD 2.3 billion by 2033. This growth is fueled by advancements in next-generation sequencing (NGS), rising investments in genomic research, and the expanding role of molecular diagnostics in personalized healthcare.

Loading chart…

Key drivers shaping the DNA & RNA Extraction market include technological innovation in automated extraction systems, which enhance efficiency and reduce contamination risks, and regulatory mandates promoting genomic testing for early disease detection. North America remains the largest region due to advanced biotechnology ecosystems, while Asia-Pacific is the fastest-growing market, driven by increasing healthcare digitization and government-funded genomics initiatives. Competitive intensity is rising as players invest in AI-integrated workflows and sustainable extraction reagents to address evolving industry needs.

Report Overview

Report Attribute	Details
Market size value in 2025	4.47 billion
Revenue forecast in 2033	7.80 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche Life Science; Thermo Fisher Scientific; Qiagen; Merck Millipore; Agilent Technologies; Bio-Rad; Illumina; PerkinElmer; LGC; Promega; Kurabo Biomedical; Analytik Jena; AutoGen; Hain Lifescience; ELITech; Biosan; Bioneer; Genolution; GeneReach; Takara Bio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advancements in Next-Generation Sequencing (NGS): The proliferation of NGS applications in oncology, microbiology, and rare disease diagnostics is driving demand for high-purity DNA & RNA, directly boosting the DNA & RNA Extraction market size. Technological innovations in automated extraction platforms are further accelerating adoption in high-throughput labs.

Expansion of Personalized Medicine Initiatives: Governments and pharmaceutical firms are investing heavily in genomics-based therapies, requiring large-scale DNA & RNA sample processing. This trend is fueling the growth forecast for the market, particularly in regions with robust healthcare IT infrastructure.

Restraints2 items

High Capital Expenditure for Advanced Systems: Premium-priced automated extraction devices and consumables limit market penetration, especially in resource-constrained healthcare systems. Small-to-midsize labs often opt for manual methods, slowing overall adoption.

Regulatory Hurdles in Sample Sourcing: Stringent biosafety regulations for handling human and animal-derived samples—particularly across international borders—create bottlenecks for research institutions and biobanks, indirectly restraining market growth.

Opportunities2 items

Rise of Point-of-Care (POC) Diagnostics: Emerging POC devices requiring rapid DNA & RNA extraction are creating untapped revenue streams, especially in decentralized healthcare settings. Partnerships between extraction kit providers and POC diagnostics firms could redefine the DNA & RNA Extraction market landscape.

Growing Demand in Environmental Genomics: Applications in metagenomics, such as tracking climate-resilient crops or monitoring biodiversity, are opening new verticals. This niche demand is attracting specialized players to diversify product portfolios.

Challenges2 items

Supply Chain Volatility for Raw Materials: Critical reagents like magnetic beads and enzymes face periodic shortages due to geopolitical disruptions or supplier consolidation, impacting production timelines and pricing stability.

Technical Complexity in Sample Heterogeneity: Extracting intact nucleic acids from challenging sources (e.g., formalin-fixed paraffin-embedded tissues) remains a technical barrier. Inconsistent yields from such samples limit reliability and require ongoing R&D investment.

Market Segmentation

Loading chart…

The Application segment of the DNA & RNA Extraction market is a critical driver of market dynamics, with clinical diagnostics and research applications dominating demand. Clinical diagnostics, accounting for approximately 45% of the DNA & RNA Extraction segmentation, is fueled by advancements in personalized medicine, infectious disease testing, and oncology biomarker identification. Research applications, including academic and pharmaceutical studies, represent 35% of the market, driven by genomic sequencing and functional genomics initiatives. Forensic analysis and agricultural biotechnology constitute the remaining 20%, reflecting niche but high-growth areas. The contribution of each application to the market size is underscored by technological adoption rates, regulatory frameworks, and the prevalence of targeted diseases.

The Types segment of the DNA & RNA Extraction market is categorized into kits, instruments, and reagents, each playing a distinct role in market evolution. Kits, which dominate the market at 55%, offer standardized protocols and ease of use, making them indispensable for high-throughput laboratories. Instruments, including automated extraction devices and traditional centrifuges, account for 30% of the market, with innovation in miniaturization and speed shaping growth trajectories. Reagents, comprising nucleic acid purification solutions and lysis buffers, capture the remaining 15%, driven by the need for specialized formulations in emerging applications. Market taxonomy analysis reveals that type-specific demand is closely tied to end-user preferences for efficiency, cost, and scalability.

DNA & RNA Extraction Segmentation Breakdown6 items

Application

Academic & Research Institutes

Pharmaceutical & Biotechnology Companies

Types

DNA/RNA Extraction Equipment

DNA/RNA Extraction Reagents

Regional Insights

Loading chart…

North America dominates the DNA & RNA Extraction market growth with a 40% share, driven by advanced healthcare infrastructure, high adoption of precision medicine, and robust R&D investments. The region benefits from a mature biotechnology ecosystem, stringent regulatory frameworks, and rising demand for molecular diagnostics. Europe follows with 30%, fueled by strong government funding for genomic research, aging demographics boosting healthcare demand, and well-established academic institutions. Asia Pacific is the fastest-growing region, projected to expand at a CAGR exceeding 12%, supported by increasing biotechnology investments, rising chronic disease prevalence, and improving diagnostic infrastructure. Latin America (10%) and the Middle East & Africa (5%) show potential, driven by growing healthcare partnerships, regional investments in genomic surveillance, and expanding public-private collaborations.

Regional Drivers5 items

North America: Advanced infrastructure, high R&D spending, and policy mandates for genomic testing.

Europe: Aging population, EU Horizon funding, and regulatory harmonization via EMA.

Asia Pacific: Proliferation of low-cost sequencing, government initiatives (e.g., India’s Genomics Mission), and rising infectious disease burden.

Latin America: Expansion of molecular labs and cross-border collaborations with North American biotech firms.

Middle East & Africa: Emerging genomic research hubs and partnerships with global diagnostics leaders.

Competitive Landscape

The DNA & RNA Extraction market exhibits a moderately consolidated structure, with a mix of global players and regional firms. Global entities dominate through diversified product portfolios and strategic geographic expansion, while local companies gain traction via cost-effective solutions and niche market targeting. The DNA & RNA Extraction competitive landscape is shaped by product innovation (e.g., automated systems), regulatory compliance in high-growth regions, and strategic partnerships with diagnostics and biotech firms. Pricing remains a critical lever, particularly in price-sensitive markets, though premium offerings emphasize high-throughput and multiplexing capabilities.

Competitive differentiation centers on technology (e.g., magnetic bead vs. silica membrane methods), service models (e.g., kit-as-a-service), and channel strength through academic, clinical, and industrial verticals. Common strategies include M&A to fill portfolio gaps, R&D investments in AI-driven extraction tools, and localization to mitigate supply chain risks. A key challenge is margin pressure from commoditization of basic extraction kits, pushing firms to reposition toward premium solutions with end-to-end workflow integration.

Roche Life Science: Focus on premium pricing and integrated diagnostic workflow solutions

Thermo Fisher Scientific: Vertical integration via in-house manufacturing and OEM tie-ups

Qiagen: Expansion of automation-compatible reagent portfolios for high-throughput labs

Merck Millipore: Partnerships with biobanking networks to secure long-term procurement contracts

Agilent Technologies: R&D investment in miniaturized, field-deployable extraction devices

Bio-Rad: Localization strategy with regional manufacturing hubs in Asia-Pacific markets

Key DNA & RNA Extraction Companies20 items

Roche Life Science

Thermo Fisher Scientific

Qiagen

Merck Millipore

Agilent Technologies

Bio-Rad

Illumina

PerkinElmer

LGC

Promega

Kurabo Biomedical

Analytik Jena

AutoGen

Hain Lifescience

ELITech

Biosan

Bioneer

Genolution

GeneReach

Takara Bio

Market Ecosystem

The DNA & RNA Extraction market ecosystem spans raw material sourcing, extraction technology development, and application-specific deployment across research, diagnostics, and biotechnology sectors. Value is generated through innovation in extraction methodologies and downstream validation of extracted nucleic acids, with control concentrated in technology licensing, equipment integration, and regulatory compliance.

Raw material/component suppliers — provide reagents, consumables, and specialized equipment for extraction workflows

Technology providers — develop proprietary kits, automation platforms, and software for nucleic acid isolation

OEMs — manufacture extraction instruments and validate system performance for end-user applications

System integrators — configure multi-vendor solutions for high-throughput or point-of-care use cases

Distributors/channel partners — manage logistics, sales, and technical support for end-user access

End users — apply extraction systems in clinical, agricultural, or forensic settings for downstream analysis

Regulators/standards bodies — define quality, safety, and validation requirements for extraction processes

Control points reside with technology providers and regulators, who influence adoption through IP licensing and compliance frameworks. Dependency risks include raw material scarcity and evolving validation protocols. High switching costs for end users arise from platform-specific validation requirements and interoperability constraints between extraction systems.

Recent Industry Insights

The DNA & RNA Extraction industry trends over the past 18 months reflect a surge in innovation driven by advancements in genomic research and diagnostic demands. Key players such as Thermo Fisher Scientific and Promega have formed strategic partnerships to enhance sample preparation workflows, while QIAGEN’s acquisition of a next-generation sequencing startup in early 2024 underscores the sector’s focus on vertical integration. Regulatory updates by the FDA in late 2023, emphasizing standardized protocols for RNA vaccines, have also accelerated R&D investments. Meanwhile, the rise of point-of-care testing has spurred product launches, including automated extraction systems by companies like Bio-Rad and Roche, addressing the need for rapid, high-throughput solutions. Funding activity remains robust, with startups securing over $200 million in Series B rounds to develop AI-driven extraction technologies. Enterprises are prioritizing sustainability, shifting toward eco-friendly reagents and reusable kits, signaling a long-term pivot toward green biotechnology.

Enterprise trends highlight a growing reliance on cloud-based data analytics for extraction process optimization, while consumer demand for at-home genetic testing kits continues to expand. This dual pressure is pushing manufacturers to balance scalability with cost efficiency, ensuring adaptability in a market poised for exponential growth through 2026.

Analyst Overview

Market Attractiveness: The DNA & RNA Extraction market remains highly attractive, driven by advancements in genomics, personalized medicine, and next-generation sequencing (NGS). Growing demand from biopharma R&D, diagnostic innovation, and agricultural biotechnology underscores its strategic value.

Competitive Intensity: While dominated by established players like Thermo Fisher Scientific and Qiagen, the market sees rising competition from niche innovators. Partnerships, geographic expansion, and product differentiation are key strategies to maintain edge.

Long-term Outlook: The DNA & RNA Extraction market outlook is optimistic, with sustained growth projected through 2030. Rising applications in infectious disease surveillance and single-cell analysis will fuel expansion, particularly in emerging economies.

Innovation Landscape: Innovation is accelerating, emphasizing automation, miniaturization, and non-invasive sample collection. Breakthroughs in RNA-based therapies and AI-driven extraction protocols are reshaping efficiency and accuracy benchmarks.

Demand–Supply Balance: Current demand, especially for high-throughput solutions, outpaces supply capacity. Strategic collaborations and scaled manufacturing investments are critical to addressing shortages in regions with nascent biotech ecosystems.

Key Risk Factors3 items

Regulatory shifts impacting cross-border sample transportation

Contamination risks in low-cost extraction workflows

Intellectual property disputes in rapidly evolving tech segments

11 items

1. Executive Summary

2. DNA & RNA Extraction Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global DNA & RNA Extraction Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global DNA & RNA Extraction Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Academic & Research Institutes

6.1.2. Pharmaceutical & Biotechnology Companies

6.2. Global DNA & RNA Extraction Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. DNA/RNA Extraction Equipment

6.2.2. DNA/RNA Extraction Reagents

6.3. Global DNA & RNA Extraction Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global DNA & RNA Extraction Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global DNA & RNA Extraction Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global DNA & RNA Extraction Market Competition by Key Manufacturers

8.1. Global DNA & RNA Extraction Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global DNA & RNA Extraction: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Roche Life Science

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Thermo Fisher Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Qiagen

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Merck Millipore

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Agilent Technologies

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Bio-Rad

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Illumina

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. PerkinElmer

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. LGC

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Promega

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Kurabo Biomedical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Analytik Jena

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. AutoGen

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Hain Lifescience

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. ELITech

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Biosan

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Bioneer

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Genolution

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. GeneReach

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Takara Bio

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global DNA & RNA Extraction Market

Figure 4: Global DNA & RNA Extraction Market: Drivers

Figure 5: Global DNA & RNA Extraction Market: Challenges

Figure 6: Global DNA & RNA Extraction Market: Trends

Figure 7: Global DNA & RNA Extraction Market: Opportunity

Figure 8: Global DNA & RNA Extraction Market: Restraint

Figure 9: Global DNA & RNA Extraction Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global DNA & RNA Extraction Market Value (USD Million) By Region

Figure 15: Global DNA & RNA Extraction Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global DNA & RNA Extraction Market Value (USD Million) By Region

Figure 23: Global DNA & RNA Extraction Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

93 items

Table 1: Market Segmentation Analysis

Table 2: Global DNA & RNA Extraction Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global DNA & RNA Extraction Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global DNA & RNA Extraction Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global DNA & RNA Extraction Market Value (USD Million) By Region

Table 10: Global DNA & RNA Extraction Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global DNA & RNA Extraction Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global DNA & RNA Extraction Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global DNA & RNA Extraction Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Roche Life Science Basic Information And Sales Area

Table 31: Roche Life Science. Products Portfolio

Table 32: Thermo Fisher Scientific Basic Information And Sales Area

Table 33: Thermo Fisher Scientific. Products Portfolio

Table 34: Qiagen Basic Information And Sales Area

Table 35: Qiagen. Products Portfolio

Table 36: Merck Millipore Basic Information And Sales Area

Table 37: Merck Millipore. Products Portfolio

Table 38: Agilent Technologies Basic Information And Sales Area

Table 39: Agilent Technologies. Products Portfolio

Table 40: Bio-Rad Basic Information And Sales Area

Table 41: Bio-Rad. Products Portfolio

Table 42: Illumina Basic Information And Sales Area

Table 43: Illumina. Products Portfolio

Table 44: PerkinElmer Basic Information And Sales Area

Table 45: PerkinElmer. Products Portfolio

Table 46: LGC Basic Information And Sales Area

Table 47: LGC. Products Portfolio

Table 48: Promega Basic Information And Sales Area

Table 49: Promega. Products Portfolio

Table 50: Kurabo Biomedical Basic Information And Sales Area

Table 51: Kurabo Biomedical. Products Portfolio

Table 52: Analytik Jena Basic Information And Sales Area

Table 53: Analytik Jena. Products Portfolio

Table 54: AutoGen Basic Information And Sales Area

Table 55: AutoGen. Products Portfolio

Table 56: Hain Lifescience Basic Information And Sales Area

Table 57: Hain Lifescience. Products Portfolio

Table 58: ELITech Basic Information And Sales Area

Table 59: ELITech. Products Portfolio

Table 60: Biosan Basic Information And Sales Area

Table 61: Biosan. Products Portfolio

Table 62: Bioneer Basic Information And Sales Area

Table 63: Bioneer. Products Portfolio

Table 64: Genolution Basic Information And Sales Area

Table 65: Genolution. Products Portfolio

Table 66: GeneReach Basic Information And Sales Area

Table 67: GeneReach. Products Portfolio

Table 68: Takara Bio Basic Information And Sales Area

Table 69: Takara Bio. Products Portfolio

Table 70: Global Market Value (USD Million) (2025-2032) By Application

Table 71: Global Market Share (%) By Application (2032)

Table 72: Global Market Value (USD Million) (2025-2032) By Types

Table 73: Global Market Share (%) By Types (2032)

Table 74: Global DNA & RNA Extraction Market Value (USD Million) By Region

Table 75: Global DNA & RNA Extraction Market Share (%) By Region (2025-2032)

Table 76: North America Market Value (USD Million) (2025-2032) By Country

Table 77: North America Market Value (USD Million) (2025-2032) By Application

Table 78: North America Market Value (USD Million) (2025-2032) By Types

Table 79: Europe Market Value (USD Million) (2025-2032) By Country

Table 80: Europe Market Value (USD Million) (2025-2032) By Application

Table 81: Europe Market Value (USD Million) (2025-2032) By Types

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 85: South America Market Value (USD Million) (2025-2032) By Country

Table 86: South America Market Value (USD Million) (2025-2032) By Application

Table 87: South America Market Value (USD Million) (2025-2032) By Types

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 91: Research Programs/Design For This Report

Table 92: Key Data Information From Secondary Sources

Table 93: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

DNA & RNA Extraction Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.47 billion
Revenue forecast in 2033	7.80 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche Life Science; Thermo Fisher Scientific; Qiagen; Merck Millipore; Agilent Technologies; Bio-Rad; Illumina; PerkinElmer; LGC; Promega; Kurabo Biomedical; Analytik Jena; AutoGen; Hain Lifescience; ELITech; Biosan; Bioneer; Genolution; GeneReach; Takara Bio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

DNA & RNA Extraction Segmentation Breakdown6 items

Application

Academic & Research Institutes

Pharmaceutical & Biotechnology Companies

Types

DNA/RNA Extraction Equipment

DNA/RNA Extraction Reagents

Regional Insights

Loading chart…

Regional Drivers5 items

North America: Advanced infrastructure, high R&D spending, and policy mandates for genomic testing.

Europe: Aging population, EU Horizon funding, and regulatory harmonization via EMA.

Asia Pacific: Proliferation of low-cost sequencing, government initiatives (e.g., India’s Genomics Mission), and rising infectious disease burden.

Latin America: Expansion of molecular labs and cross-border collaborations with North American biotech firms.

Middle East & Africa: Emerging genomic research hubs and partnerships with global diagnostics leaders.

Competitive Landscape

Roche Life Science: Focus on premium pricing and integrated diagnostic workflow solutions

Thermo Fisher Scientific: Vertical integration via in-house manufacturing and OEM tie-ups

Qiagen: Expansion of automation-compatible reagent portfolios for high-throughput labs

Merck Millipore: Partnerships with biobanking networks to secure long-term procurement contracts

Agilent Technologies: R&D investment in miniaturized, field-deployable extraction devices

Bio-Rad: Localization strategy with regional manufacturing hubs in Asia-Pacific markets

Key DNA & RNA Extraction Companies20 items

Roche Life Science

Thermo Fisher Scientific

Qiagen

Merck Millipore

Agilent Technologies

Bio-Rad

Illumina

PerkinElmer

LGC

Promega

Kurabo Biomedical

Analytik Jena

AutoGen

Hain Lifescience

ELITech

Biosan

Bioneer

Genolution

GeneReach

Takara Bio

Market Ecosystem

Raw material/component suppliers — provide reagents, consumables, and specialized equipment for extraction workflows

Technology providers — develop proprietary kits, automation platforms, and software for nucleic acid isolation

OEMs — manufacture extraction instruments and validate system performance for end-user applications

System integrators — configure multi-vendor solutions for high-throughput or point-of-care use cases

Distributors/channel partners — manage logistics, sales, and technical support for end-user access

End users — apply extraction systems in clinical, agricultural, or forensic settings for downstream analysis

Regulators/standards bodies — define quality, safety, and validation requirements for extraction processes

Recent Industry Insights

Analyst Overview

Key Risk Factors3 items

Regulatory shifts impacting cross-border sample transportation

Contamination risks in low-cost extraction workflows

Intellectual property disputes in rapidly evolving tech segments

Table of Contents